The Chicago Entrepreneur

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

Liraglutide is sold under the brand names Saxenda and Victoza, and sales are declining as blockbuster GLP-1s Ozempic and Wegovy skyrocket in demand.

Previous post Beam me here, Scotty, to this ‘Star Trek’-inspired home for sale in San Francisco for $3.9 million
Next post Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda